225 related articles for article (PubMed ID: 25036544)
1. Photodynamic therapy for choroidal hemangioma unresponsive to ranibizumab.
Chan LW; Hsieh YT
Optom Vis Sci; 2014 Sep; 91(9):e226-9. PubMed ID: 25036544
[TBL] [Abstract][Full Text] [Related]
2. Choroidal neovascular membrane in a treated choroidal hemangioma.
Nagesha CK; Walinjkar JA; Khetan V
Indian J Ophthalmol; 2016 Aug; 64(8):606-8. PubMed ID: 27688287
[TBL] [Abstract][Full Text] [Related]
3. Low-fluence photodynamic therapy versus ranibizumab for chronic central serous chorioretinopathy: one-year results of a randomized trial.
Bae SH; Heo J; Kim C; Kim TW; Shin JY; Lee JY; Song SJ; Park TK; Moon SW; Chung H
Ophthalmology; 2014 Feb; 121(2):558-65. PubMed ID: 24268858
[TBL] [Abstract][Full Text] [Related]
4. Choroidal haemangioma and photodynamic therapy. Anatomical and functional response of patients with choroidal hemangioma treated with photodynamic therapy.
Subirà O; Brosa H; Lorenzo-Parra D; Arias-Barquet L; Català-Mora J; Cobos E; Garcia-Bru P; Rubio-Caso MJ; Caminal-Mitjana JM
Arch Soc Esp Oftalmol; 2017 Jun; 92(6):257-264. PubMed ID: 28017484
[TBL] [Abstract][Full Text] [Related]
5. Treatment of serous macular detachment associated with circumscribed choroidal hemangioma.
Kwon HJ; Kim M; Lee CS; Lee SC
Am J Ophthalmol; 2012 Jul; 154(1):137-145.e1. PubMed ID: 22465363
[TBL] [Abstract][Full Text] [Related]
6. Comparisons of outcomes with different intervals between adjunctive ranibizumab and photodynamic therapy for polypoidal choroidal vasculopathy.
Sato T; Kishi S; Matsumoto H; Mukai R
Am J Ophthalmol; 2013 Jul; 156(1):95-105.e1. PubMed ID: 23628354
[TBL] [Abstract][Full Text] [Related]
7. Combination treatment of photodynamic therapy with verteporfin and intravitreal ranibizumab in patients with retinal angiomatous proliferation.
Seidel G; Werner C; Weger M; Steinbrugger I; Haas A
Acta Ophthalmol; 2013 Sep; 91(6):e482-5. PubMed ID: 23786546
[TBL] [Abstract][Full Text] [Related]
8. Reduced-fluence photodynamic therapy in polypoidal choroidal vasculopathy nonresponsive to ranibizumab.
Byon IS; Kwon HJ; Kim SI; Shin MK; Park SW; Lee JE
Ophthalmic Surg Lasers Imaging Retina; 2014; 45(6):534-41. PubMed ID: 25423633
[TBL] [Abstract][Full Text] [Related]
9. Prospective clinical trial evaluating the efficacy of photodynamic therapy for symptomatic circumscribed choroidal hemangioma.
Boixadera A; García-Arumí J; Martínez-Castillo V; Encinas JL; Elizalde J; Blanco-Mateos G; Caminal J; Capeans C; Armada F; Navea A; Olea JL
Ophthalmology; 2009 Jan; 116(1):100-105.e1. PubMed ID: 18973950
[TBL] [Abstract][Full Text] [Related]
10. Optical coherence tomography for evaluation of photodynamic therapy in symptomatic circumscribed choroidal hemangioma.
Liu W; Zhang Y; Xu G; Qian J; Jiang C; Li L
Retina; 2011 Feb; 31(2):336-43. PubMed ID: 21102373
[TBL] [Abstract][Full Text] [Related]
11. Photodynamic therapy with verteporfin for symptomatic circumscribed choroidal hemangioma: five-year outcomes.
Blasi MA; Tiberti AC; Scupola A; Balestrazzi A; Colangelo E; Valente P; Balestrazzi E
Ophthalmology; 2010 Aug; 117(8):1630-7. PubMed ID: 20417564
[TBL] [Abstract][Full Text] [Related]
12. A randomized pilot study of low-fluence photodynamic therapy versus intravitreal ranibizumab for chronic central serous chorioretinopathy.
Bae SH; Heo JW; Kim C; Kim TW; Lee JY; Song SJ; Park TK; Moon SW; Chung H
Am J Ophthalmol; 2011 Nov; 152(5):784-92.e2. PubMed ID: 21742303
[TBL] [Abstract][Full Text] [Related]
13. Combined intravitreal ranibizumab and photodynamic therapy for polypoidal choroidal vasculopathy.
Saito M; Iida T; Kano M
Retina; 2012 Jul; 32(7):1272-9. PubMed ID: 22547209
[TBL] [Abstract][Full Text] [Related]
14. Resolution of advanced cystoid macular edema following photodynamic therapy for choroidal hemangioma.
Shields CL; Materin MA; Marr BP; Mashayekhi A; Shields JA
Ophthalmic Surg Lasers Imaging; 2005; 36(3):237-9. PubMed ID: 15957481
[TBL] [Abstract][Full Text] [Related]
15. Photodynamic therapy for symptomatic circumscribed macular choroidal hemangioma in Chinese patients.
Zhang Y; Liu W; Fang Y; Qian J; Xu G; Wang W; Li L; Shen Y; Gao Q
Am J Ophthalmol; 2010 Nov; 150(5):710-715.e1. PubMed ID: 20709311
[TBL] [Abstract][Full Text] [Related]
16. Polypoidal choroidal vasculopathy following photodynamic therapy for choroidal hemangioma.
Tuncer S; Demirci H; Shields CL; Shields JA
Eur J Ophthalmol; 2009; 19(1):159-62. PubMed ID: 19123168
[TBL] [Abstract][Full Text] [Related]
17. Photodynamic therapy for choroidal hemangioma associated with serous retinal detachment.
Robertson DM
Arch Ophthalmol; 2002 Sep; 120(9):1155-61. PubMed ID: 12215088
[TBL] [Abstract][Full Text] [Related]
18. Comparison between anti-vascular endothelial growth factor therapy and photodynamic therapy for myopic choroidal neovascularization.
Matsuo M; Honda S; Matsumiya W; Kusuhara S; Tsukahara Y; Negi A
Eur J Ophthalmol; 2012; 22(2):210-5. PubMed ID: 21534251
[TBL] [Abstract][Full Text] [Related]
19. EVEREST study: efficacy and safety of verteporfin photodynamic therapy in combination with ranibizumab or alone versus ranibizumab monotherapy in patients with symptomatic macular polypoidal choroidal vasculopathy.
Koh A; Lee WK; Chen LJ; Chen SJ; Hashad Y; Kim H; Lai TY; Pilz S; Ruamviboonsuk P; Tokaji E; Weisberger A; Lim TH
Retina; 2012 Sep; 32(8):1453-64. PubMed ID: 22426346
[TBL] [Abstract][Full Text] [Related]
20. Intravitreal anti-vascular endothelial growth factor therapy versus photodynamic therapy for idiopathic choroidal neovascularization.
Kang HM; Koh HJ
Am J Ophthalmol; 2013 Apr; 155(4):713-9, 719.e1. PubMed ID: 23219069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
